Bo Li
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology top 5%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Topics
- Cancer-related molecular mechanisms research (33 papers)RNA modifications and cancer (27 papers)Epigenetics and DNA Methylation (19 papers)
- Journals
- Proceedings of the National Academy of SciencesNature CommunicationsSHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Bo Li
174 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 156
- Molecular Biology 1.6k
- Cancer Research 903
- Oncology 685
- Immunology 373
- Pulmonary and Respiratory Medicine 332
Countries citing papers authored by Bo Li
This map shows the geographic impact of Bo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Li more than expected).
Fields of papers citing papers by Bo Li
This network shows the impact of papers produced by Bo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Li. The network helps show where Bo Li may publish in the future.
Co-authorship network of co-authors of Bo Li
This figure shows the co-authorship network connecting the top 25 collaborators of Bo Li. A scholar is included among the top collaborators of Bo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Li. Bo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 5 | |
| 8 | 24 | |
| 9 | 8 | |
| 10 | 55 | |
| 11 | 16 | |
| 12 | 2 | |
| 13 | 9 | |
| 14 | Development and Validation of a Risk Nomogram Model for Perioperative Respiratory Adverse Events in Children Undergoing Airway Surgery: An Observational Prospective Cohort Study | 5 |
| 15 | 3 | |
| 16 | 4 | |
| 17 | 4 | |
| 18 | 3 | |
| 19 | 2 | |
| 20 | 71 |
About Bo Li
Bo Li is a scholar working on Cancer Research, Oncology and Gastroenterology, having authored 184 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (33 papers), RNA modifications and cancer (27 papers) and Epigenetics and DNA Methylation (19 papers). The work is most often cited by research in Cancer Research (903 citations), Oncology (685 citations) and Molecular Biology (1.6k citations). Bo Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Pingting Zhou, Yuanhua Liu, Yao Yuan, Dong Li, Meichao Zhang, Changhua Zhang, Yulong He, Fu-Rao Liu, Qian Wang and Chunming Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.